Infectious Diseases and Neurosurgical Care in Latin America: Challenges and Opportunities in Global Neurosurgery

Global neurosurgery in Latin America unfolds against a backdrop of fiscal austerity, rugged geography, and an unfinished infectious disease agenda [1]. While non communicable ailments rise, parasitic and bacterial pathogens persist, forging a “double burden” that stretches already thin subspecialty services [2]. The high burden of infectious diseases leading to neurosurgical conditions in Latin America reflects broader public health failures, including inadequate sanitation infrastructure, limited access to clean water, and insufficient zoonotic disease control measures [3]. These factors contribute to the persistence of parasitic and bacterial infections that can involve the central nervous system, requiring complex neurosurgical interventions. The disproportionate impact on rural, low-resource populations exacerbates existing health disparities and challenges the capacity of neurosurgical services to meet population needs effectively. Poor sanitation, scarce potable water, and porous zoonotic control programs keep neuro invasive infections alive, striking hardest in rural districts where neurosurgical reach is weakest [3]. The implications are not purely clinical: Every delayed shunt or missed tuberculoma biopsy reverberates through families’ finances and fragile health system budgets-an under reported economic toll that warrants sharper policy attention.

Neurocysticercosis (NC), the larval Taenia solium infestation, remains the region’s most impactful parasitosis of the brain [4]. Its epidemiology mirrors poverty; Its clinical palette spans silent nodules to explosive seizures [5]. Parenchymal cysts usually succumb to cysticidals; Extraparenchymal disease, by contrast, resists medication and drives surgical consults [4]. Standard armamentarium ventriculoperitoneal shunting, Endoscopic Third Ventriculostomy (ETV), and direct cyst extraction-has evolved with endoscopy now proving both safe and shunt sparing in resource limited settings [6]. Longitudinal national data illustrate uneven progress. Between 1998 and 2019, Brazil, Ecuador, and Mexico recorded significant NC admission declines and an aging patient pool, hinting at reduced recent transmission [4]. Colombia, however, registered a marked rise from 2009 to 2019, underscoring heterogenous control [4]. Surveillance gaps blur the true prevalence-the WHO still lists cysticercosis among the “neglected” tropical diseases, and most ministries of health do not mandate case notification. Thus, today’s operating room statistics may be merely the visible tip of a community iceberg. Technically, Latin American teams have pushed the envelope with ventricle scopic cystectomy under flexible endoscopes that navigate the aqueduct, a maneuver rarely attempted elsewhere. Early series report >90 % cyst clearance with hydrocephalus resolution in two thirds of cases, obviating lifelong shunt surveillance-a crucial advantage where valve revisions cost months of household income [7]

Tuberculosis of the central nervous system persists where migration, deprivation, and HIV intersect [8]. Tuberculomas, especially in the brain stem, masquerade as neoplasms and demand diagnostic vigilance [9]. Pontine lesions typically present with cranial nerve VI/VII palsies, long tract signs, and cerebellar dysfunction; MRI reveals iso /hypointense T1 cores rimmed by hyperintense T2 halos [9]. When imaging is equivocal, stereotactic biopsy remains the neurosurgeon’s compass, although intra operative smears rarely clinch the diagnosis and culture often fails [9]. Histology plus clinical context-immunosuppression profile, systemic work up-guides anti-tuberculous therapy, with resection reserved for mass effect or obstructive scenarios [10]. Yet access to frame based stereotaxy outside capitals is patchy; Some provinces triage by age and glasgow score, a triage system that inevitably leaves marginalised patients untreated. Emergent collaborations with telepathology hubs in Mexico City and São Paulo have shortened the diagnostic loop, but scale up remains slow.

Although NC and CNS TB dominate headlines, bacterial brain abscess secondary to chronic otitis media and frontal sinusitis still populate operating logs-especially in the tropical belt where antibiotic courses are often truncated. Antimicrobial resistance, now rampant in regional hospitals, complicates empiric therapy, prolongs ICU stays, and inflates costs. Fungal meningitis, most notably cryptococcosis in HIV positive or transplant patients, often culminates in repeated lumbar punctures or lumboperitoneal shunts to temper intracranial hypertension. Furthermore, emerging arboviruses-dengue, Zika, chikungunya-carry neuro inflammatory sequelae; Guillain Barré flares and viral encephalitis swell ICU occupancy, indirectly siphoning theatre slots and nursing staff from elective cerebrovascular cases.

Geography and economics conspire against timely neurosurgical intervention. Advanced imaging still clusters in capitals, delaying rural diagnoses of shunt worthy hydrocephalus or space occupying tuberculomas [2,11]. The continent averages 1.4 CT scanners per million inhabitants versus >40 in high income countries, and even when devices exist, downtime for maintenance frequently exceeds usable hours. Workforce maldistribution is stark: The hospital del Niño in la paz functions as the lone public pediatric neurosurgical node for 2.9 million inhabitants [1]. Chile and Uruguay approach the recommended 1 neurosurgeon per 100,000 citizens, but Bolivia, Honduras, and Haiti operate at half that ratio. Fragile health system scaffolding magnifies every access barrier, nowhere more evident than in neuro infectious emergencies. Operating room backlogs now echo through the ward: In Bolivia the median admission to scalpel interval for pediatric cases lengthened from 1.9 days in 2019 to 2.5 days in 2023-an incremental stall that disproportionately punishes time critical pathologies such as ventriculocysticercal hydrocephalus and brain stem tuberculomas exerting inexorable mass effect [1].

Each half day lost translates into rising intracranial pressure, deteriorating neurology, and a steeper operative curve once theatre finally opens. Public neuro literacy is equally brittle. In Brazil, 22 % of respondents across three metropolitan hubs failed to name a single neurological “red flag,” while in Colombia 65.3 % could not recognise warning signs and only 11.7 % would seek urgent care when faced with them [2]. Headaches, episodic confusion, or brief focal deficits-early harbingers of neurocysticercosis or CNS tuberculosis-are thus routinely dismissed until seizures erupt or herniation looms, converting what could have been elective diversion or minimally invasive biopsy into midnight craniotomy and prolonged ICU stay [2]. These twin failures-logistical latency and community unawareness-set off a vicious spiral. Delayed presentation compounds surgical complexity; Longer, riskier procedures lengthen postoperative recovery, occupy scarce beds, and inflate costs. The resulting throughput bottleneck pushes the next wave of patients even further down the queue, amplifying morbidity and mortality in settings already starved of neurosurgical manpower and high dependency infrastructure.

Despite the obstacles, the region is primed for high impact wins. First, robust surveillance and shared registries can map true burden and outcomes. Mobile phone-based case reporting pilots in Guatemala have already doubled national cysticercosis notifications in 18 months, revealing previously “silent” clusters in the western highlands. Second, joint training modules-infectious disease meets neurosurgery-should teach early red flags, optimal surgical timing, and integrated medical surgical protocols. The Latin American Neurosurgical society’s new fellowship rotating residents through TB clinics in Medellín and endoscopic suites in Lima exemplifies this cross-pollination model. Third, tele neurosurgery can bridge distance. In Honduras, real time intra operative video mentoring trimmed shunt complication rates from 18% to 7% within a year. Such platforms, while bandwidth hungry, cost far less than deploying full expatriate teams. Fourth, public health levers (water, sanitation, pig husbandry, TB HIV co control) tackle root causes [7]. Cluster randomised trials in Veracruz show that latrine upgrades plus community porcine vaccination can halve human cysticercosis seroprevalence in two years. Technologically, endoscopic strategies for NC hydrocephalus epitomize low morbidity, low maintenance solutions. Local manufacturing of reusable endoscope sheaths and 3D printed ventricular models for simulation training continue to drop costs. Researchers should exploit this window to design pragmatic trials that answer local questions: Which hydrocephalus variants fare best with ETV versus shunting? What is the cost effectiveness of routine anti-helminthic prophylaxis in endemic hamlets?

Infectious diseases continue to seed a preventable neurosurgical load across Latin America. Tailored, evidence-based strategiesspanning sanitation reform to minimally invasive surgery-can bend the curve. Country specific successes show the path; Regional collaboration can amplify them. By weaving infection control into global neurosurgery training, financing, and policy, we can shift the narrative from reactive surgery to proactive prevention-freeing operating rooms for the maladies no public health measure can avert.

1. Victor ML, Jorge DB, Toba NN, David JB (2024) Assessing pediatric neurosurgery capacity in La Paz, Bolivia: An illustrative institutional experience of a lower-middle-income country in South America. J Neurosurg Pediatr 34(2): 190-198.
2. Silva GS, Maldonado NJ, Claassen J, Varelas P, Suarez JI, et al. (2019) Neuroemergencies in South America: How to fill in the gaps? Neurocrit Care 31(3): 573-582.
3. (2012) Surgical case of subacute headache in a young Latin American woman. Pathog Glob Health 106: 305-309.
4. Rodriguez RR, Flisser A, Norcia LF, Arturo C, Agnès F, et al. (2022) Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries. PLoS Negl Trop Dis 16(8): e0010652.
5. Kusnoto K, Kristiawan AR, Kartikasari MKJ (2025) Global prevalence and distribution of tape soles: A systematic review and meta-analysis. Open Vet J 15(3): 1101-1115.
6. Bonaventura RD, Quintino GDA, Liverana L (2019) Surgical case of subacute headache in a young Latin American woman. BMJ Case Rep 12(4): e228459.
7. Ramos ZR (2013) Editorial: Neurocysticercosis prevention strategies in endemic areas. World Neurosurg 80(5): e141-e142.
8. Muzumdar D (2011) Central nervous system infections and the neurosurgeon: A perspective. Int J Surg 9(2): 113-116.
9. Jimenez FP, Pérez CNS, Beltrán JQ, Ylián RT, Eric GA, et al. (2025) Pontine tuberculoma mimicking an astrocytic tumor: A case report. Cureus 17(3): e80881.
10. Dattatraya M (2011) Central nervous system infections and the neurosurgeon: A perspective. Int J Surg 9(2): 113-116.
11. Strobbe BM, Luis EMO, Lixardo C (2018) Othello syndrome secondary to cerebral tuberculoma: A case report. Rev Colomb Psiquiatr (Engl Ed) 49(2): 116-120.